Nova (NVMI) Competitors $183.00 -1.71 (-0.93%) Closing price 04:00 PM EasternExtended Trading$184.48 +1.48 (+0.81%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVMI vs. TER, RVTY, AVTR, BIO.B, VNT, MIR, ST, CAMT, TXG, and TRNSShould you be buying Nova stock or one of its competitors? The main competitors of Nova include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry. Nova vs. Teradyne Revvity Avantor Bio-Rad Laboratories Vontier Mirion Technologies Sensata Technologies Camtek 10x Genomics Transcat Nova (NASDAQ:NVMI) and Teradyne (NASDAQ:TER) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, community ranking, risk, institutional ownership and dividends. Is NVMI or TER more profitable? Nova has a net margin of 27.33% compared to Teradyne's net margin of 19.23%. Nova's return on equity of 22.33% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Nova27.33% 22.33% 15.01% Teradyne 19.23%19.08%14.47% Does the MarketBeat Community favor NVMI or TER? Nova received 369 more outperform votes than Teradyne when rated by MarketBeat users. Likewise, 74.51% of users gave Nova an outperform vote while only 48.07% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformNovaOutperform Votes45674.51% Underperform Votes15625.49% TeradyneOutperform Votes8748.07% Underperform Votes9451.93% Do analysts prefer NVMI or TER? Nova presently has a consensus price target of $277.00, suggesting a potential upside of 52.95%. Teradyne has a consensus price target of $117.56, suggesting a potential upside of 53.19%. Given Teradyne's higher probable upside, analysts plainly believe Teradyne is more favorable than Nova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nova 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Teradyne 2 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.65 Which has better earnings and valuation, NVMI or TER? Teradyne has higher revenue and earnings than Nova. Teradyne is trading at a lower price-to-earnings ratio than Nova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNova$743.95M7.16$183.76M$6.6227.36Teradyne$2.91B4.24$542.37M$3.5421.68 Does the media favor NVMI or TER? In the previous week, Teradyne had 21 more articles in the media than Nova. MarketBeat recorded 31 mentions for Teradyne and 10 mentions for Nova. Nova's average media sentiment score of 1.46 beat Teradyne's score of 1.12 indicating that Nova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nova 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 21 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, NVMI or TER? Nova has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Do institutionals & insiders hold more shares of NVMI or TER? 83.0% of Nova shares are owned by institutional investors. Comparatively, 99.8% of Teradyne shares are owned by institutional investors. 1.0% of Nova shares are owned by insiders. Comparatively, 0.2% of Teradyne shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryNova beats Teradyne on 11 of the 19 factors compared between the two stocks. Get Nova News Delivered to You Automatically Sign up to receive the latest news and ratings for NVMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVMI vs. The Competition Export to ExcelMetricNovaOptical instruments & lenses IndustryComputer SectorNASDAQ ExchangeMarket Cap$5.28B$13.87B$25.05B$8.39BDividend YieldN/A1.56%2.89%4.10%P/E Ratio31.3038.5344.3319.70Price / Sales7.165.442,122.68122.35Price / Cash38.8220.2234.7834.62Price / Book5.676.476.704.50Net Income$183.76M$324.03M$739.31M$248.22M7 Day Performance-5.56%-0.30%-1.06%-0.80%1 Month Performance-0.42%10.87%11.37%11.52%1 Year Performance-14.08%-3.00%52,711.70%8.99% Nova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVMINova3.0889 of 5 stars$183.00-0.9%$277.00+51.4%-11.1%$5.38B$743.95M31.881,180News CoveragePositive NewsAnalyst UpgradeGap DownTERTeradyne4.943 of 5 stars$81.47-1.5%$117.56+44.3%-45.1%$13.07B$2.91B24.476,500Positive NewsAnalyst RevisionGap DownRVTYRevvity4.027 of 5 stars$94.31+1.1%$125.64+33.2%-19.7%$11.12B$2.77B42.6716,700Trending NewsAnalyst RevisionGap DownAVTRAvantor4.9035 of 5 stars$13.37-0.3%$18.88+41.2%-48.1%$9.11B$6.69B12.8614,500Positive NewsInsider TradeGap DownBIO.BBio-Rad LaboratoriesN/A$250.08flatN/A-10.7%$7.00B$2.54B-3.858,200VNTVontier3.9661 of 5 stars$36.96-0.3%$44.83+21.3%-12.3%$5.47B$2.96B13.448,100Positive NewsMIRMirion Technologies1.054 of 5 stars$17.54+1.8%$18.75+6.9%+63.7%$4.07B$870.20M-92.322,870Positive NewsSTSensata Technologies4.9255 of 5 stars$26.70-1.7%$34.08+27.7%-39.1%$3.91B$3.84B31.7920,800Positive NewsGap DownCAMTCamtek4.1903 of 5 stars$65.30-1.0%$90.78+39.0%-36.8%$2.98B$450.86M26.98400Analyst UpgradeGap DownTXG10x Genomics4.3929 of 5 stars$8.93-4.9%$15.81+77.0%-64.5%$1.09B$624.66M-5.881,240Analyst UpgradeGap DownTRNSTranscat1.2187 of 5 stars$81.18-0.1%$111.50+37.3%-35.6%$755.71M$272.20M43.88920Trending NewsEarnings ReportAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies Teradyne Alternatives Revvity Alternatives Avantor Alternatives Bio-Rad Laboratories Alternatives Vontier Alternatives Mirion Technologies Alternatives Sensata Technologies Alternatives Camtek Alternatives 10x Genomics Alternatives Transcat Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVMI) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nova Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.